<DOC>
	<DOCNO>NCT01238991</DOCNO>
	<brief_summary>The purpose long term extension study ass safety , tolerability immunogenicity ACC-001 QS-21 adjuvant Japanese subject mild moderate AD randomize precede P2 double blind study .</brief_summary>
	<brief_title>Long Term Extension Study Evaluating Safety , Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>QS 21</mesh_term>
	<criteria>Subjects randomize previous 3134K12202JA ( NCT00752232 ) 3134K12206JA ( NCT00959192 ) meet inclusion criterion non exclusion criterion . Screening brain MRI scan consistent diagnosis AD . MMSE score 10 . Significant neurological disease AD . Brain MRI evidence vasogenic edema precede study . Clinically significant illness .</criteria>
	<gender>All</gender>
	<minimum_age>52 Years</minimum_age>
	<maximum_age>87 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>